Search Results 211-220 of 12342 for Multiple myeloma red flag
... multiple myeloma. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
... multiple myeloma (MM). Participation eligibility ... birefringent material in Congo red-stained tissue specimens, the type must have been ... multiple myeloma; i.e. ...
Phase II will study how well the the treatment works in patients with previously treated (relapsed or refractory) multiple myeloma and kidney dysfunction.
Clinical Trials · Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma · More about research at Mayo Clinic · Mayo Clinic Footer.
Study CRB-401 is a 2-part, non-randomized, open label, multi-site Phase 1 study of bb2121 in adults with relapsed/refractory multiple myeloma (MM).
Multiple myeloma is a cancer of the plasma cells that reside inside bone marrow. Plasma cells produce certain proteins that build up the immune system. In ...
Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.